- Home
- OMIC vs NTRB Comparison
OMIC vs NTRB Comparison
Compare OMIC & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMIC
- NTRB
- Stock Information
- Founded
- OMIC 2016
- NTRB 2016
- Country
- OMIC United States
- NTRB United States
- Employees
- OMIC 127
- NTRB N/A
- Industry
- OMIC Medical/Dental Instruments
- NTRB Industrial Specialties
- Sector
- OMIC Health Care
- NTRB Health Care
- Exchange
- OMIC Nasdaq
- NTRB Nasdaq
- Market Cap
- OMIC 49.9M
- NTRB 46.4M
- IPO Year
- OMIC 2021
- NTRB N/A
- Fundamental
- Price
- OMIC $19.70
- NTRB $4.11
- Analyst Decision
- OMIC Hold
- NTRB
- Analyst Count
- OMIC 2
- NTRB 0
- Target Price
- OMIC $10.75
- NTRB N/A
- AVG Volume (30 Days)
- OMIC 21.3K
- NTRB 26.3K
- Earning Date
- OMIC 11-12-2024
- NTRB 12-04-2024
- Dividend Yield
- OMIC N/A
- NTRB N/A
- EPS Growth
- OMIC N/A
- NTRB N/A
- EPS
- OMIC N/A
- NTRB N/A
- Revenue
- OMIC $2,667,000.00
- NTRB $2,021,771.00
- Revenue This Year
- OMIC $0.82
- NTRB N/A
- Revenue Next Year
- OMIC $252.64
- NTRB N/A
- P/E Ratio
- OMIC N/A
- NTRB N/A
- Revenue Growth
- OMIC 2.77
- NTRB N/A
- 52 Week Low
- OMIC $5.34
- NTRB $2.22
- 52 Week High
- OMIC $23.41
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- OMIC 48.55
- NTRB 44.78
- Support Level
- OMIC $19.25
- NTRB $3.90
- Resistance Level
- OMIC $19.90
- NTRB $5.16
- Average True Range (ATR)
- OMIC 0.32
- NTRB 0.33
- MACD
- OMIC 0.02
- NTRB -0.01
- Stochastic Oscillator
- OMIC 54.55
- NTRB 27.04
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.